Canada: Healthcare System and Drug Regulatory Overview

The pricing and reimbursement process in Canada is considered to be challenging to pharma, and although the Patented Medicines Prices Review Board, the Common Drug Review, and the public drug plans have their distinct strategies for regulating drug prices, there is substantial variation in reimbursement between provinces.

In terms of the drug approval process, Health Canada takes longer to award marketing approval for new drugs than the European Medicines Agency (EMA). Consequently, in order to speed up the process, user fees were increased in April 2011, and from April 2012 all fees will be increased annually by 2%.

Canada lacks any workable right of appeal under its linkage system and it is the only G7 nation that does not offer any form of patent term restoration. Because of this, Canada is on the PhRMA Special 301 Watch List and major reform of the intellectual property system has been called for.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144094-canada-healthcare-system-and-drug-regulatory-overview.html

Features and benefits
• Assess the key factors facing pharma in terms of regulatory issues, pricing and reimbursement.
• Review the insurance and healthcare system in Canada including recent health reforms.
• Gain insight into regulatory and intellectual property issues in Canada.
• Review important pricing and reimbursement issues in Canada.

The pricing and reimbursement process in Canada is considered to be challenging to pharma. Furthermore, Health Canada takes longer to award marketing approval for new drugs than the European Medicines Agency (EMA). Also, while the intellectual property environment in Canada has improved in recent years, it is still considered to be behind that of other G7 countries.

Explore Table of Contents available in the report Canada: Healthcare System and Drug Regulatory Overview.

Market and Product Forecasts: COPD in China – Novel therapies to see patient potential limited by high cost

The increasing prevalence of COPD and new therapies will boost the Chinese COPD market from $204m to $317m by 2020. Spiriva will become the market leader from 2013 and maintain the position through 2020, owing to its wide application across all disease severities. A number of novel products will increase the product offering on the market, with most pipeline products aimed at more severe patients.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144096-market-and-product-forecasts-copd-in-china-novel-therapies-to-see-patient-potential-limited-by-high-cost.html

Features and benefits
• Access Datamonitor’s patient-based COPD market forecast in China, with transparent methodology and clear assumptions.
• Explore the current and future market size of COPD in China and see which key brands will impact the market.
• Gain insight into COPD market dynamics, and see where untapped market potential remains.
• Understand which factors are driving growth in the Chinese COPD market, and what challenges pipeline products face.

Highlights
Datamonitor forecasts the Chinese COPD market to increase from $204m in 2011 to $317m by 2020, at a compound annual growth rate (CAGR) over 2011–20 of 5.0%. Market growth will not only be boosted by patients continuing to switch to more convenient, and more expensive, combination drugs, but also by the increasing prevalence of COPD in China.

Datamonitor forecasts that five new therapies will enter the Chinese market over 2011–20, including the first once-daily ICS/LABA combination and LABA/LAMA combinations. While these combinations are clinically attractive, their commercial potential will be restricted by their relatively high price.

Datamonitor estimates that in 2011 Seretide and Spiriva top all brands by achieving $48m and $46m respectively, together capturing 46% of the Chinese COPD market. Spiriva will face competition from several pipeline products after 2013, but its wide clinical application across all disease severities will allow it to maintain its market dominance.

Explore Table of Contents available in the report Market and Product Forecasts: COPD in China – Novel therapies to see patient potential limited by high cost

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information on the insulin pumps market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Disposable Insulin Pumps and Traditional Insulin Pumps.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the insulin pumps market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Medtronic, Insulet Corporation, Animas Corporation and Roche.

Reasons to Buy
• Develop business strategies by understanding the trends and developments that are driving the insulin pumps globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What’s the next big thing in the insulin pumps market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global insulin pumps market and the factors shaping it.

Peru Power Market Outlook to 2030 - Market Trends, Regulation and Competitive Landscape

This report includes a detailed analysis of the current investment climate in the country’s power sector and over the next decade across 6 broad parameters. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the final country ranking in that region. The study also maps the relative ranking of the key countries in the region according to the current investment opportunities in the country and that by 2020. This report also examines the Peru Power Market  to 2030 structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market’s regulatory structure, supply and demand balance, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided.

Scope
• Analysis of the current investment climate in the country’s power sector across six parameters and over the next decade
• Relative ranking of the key country’s in the region according to the current investment opportunities in the country and that by 2020.
• Statistics for installed capacity, power generation and consumption from 2000 to 2010, forecast forward 19 years to 2030
• Break-up by technology, including thermal, hydro, renewable and nuclear
• Data on key current and upcoming projects
• Information on grid interconnectivity, distribution losses and power exports and imports
• Policy and regulatory framework governing the market
• Detailed analysis of top market participant, including market share analysis and SWOT analysis
• Data sourced from proprietary databases and primary interviews with key participants across the value chain

Reasons to Buy
Peru Power Market Outlook to 2030 - Market Trends, Regulation and Competitive Landscape
• Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country’s power sector
• Identification of key factors driving investment opportunities in the country’s power sector
• Facilitate decision-making based on strong historic and forecast data
• Develop strategies based on the latest regulatory events
• Position yourself to gain the maximum advantage of the industry’s growth potential
• Identify key partners and business development avenues
• Identify key strengths and weaknesses of important market participants
• Respond to your competitors’ business structure, strategy and prospects

Molecular Diagnostics: Market Landscape

This report Molecular Diagnostics: Market Landscape analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests that are positioned in this exciting area of diagnostics. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic market over 2010-16 provided.

Table Of Contents

ABOUT DATAMONITIOR HEALTHCARE
About the PharmaVitae Company Analysis team

ABOUT THIS REPORT
Chapter structure
Classification of molecular diagnostics
Regulation and reimbursement of molecular diagnostics
The molecular diagnostics market

EXECUTIVE SUMMARY
Strategic scoping and focus
Datamonitor key findings

CLASSIFICATION OF MOLECULAR DIAGNOSTICS
Key findings
Datamonitor’s classification of molecular diagnostics
Level 1 classification
Level 2 classification
Level 3 classification
Level 4 classification
MDx subclassification
Key applications of pharmacogenetics – introducing "personalized medicine"

REGULATION AND REIMBURSEMENT OF MOLECULAR DIAGNOSTICS
Key findings
Regulatory landscape
The FDA operates a risk-based assessment
CLIA – regulation of clinical laboratories through the CMS
Four strategic routes to approval of a diagnostic test in the US
The EU: a more simplified approach – gaining the CE mark
The diagnostics market is much smaller than the prescription pharmaceutical market…
…although it can offer some attractions to investors
However, some hurdles exist
Challenges facing the molecular diagnostics industry: US reimbursement
Challenges facing the MDx industry: intellectual property

THE MOLECULAR DIAGNOSTICS MARKET
Key findings
Introduction
The global in vitro diagnostic and molecular diagnostic markets
Historical IVD and molecular diagnostic performance, 2004–10
Current market leaders: introduction to the key players
Forecast IVD and MDx performance, 2010–16
Overview of US-approved molecular diagnostics tests

APPENDIX
The key technologies
Table of US-approved/cleared molecular diagnostic tests
References
Exchange rates

Epidemiology: Chronic Lower Back Pain – Millions will continue to be out of work over the next decade

Epidemiology: Chronic Lower Back Pain – Millions will continue to be out of work over the next decade - In 2010, Datamonitor estimates that there were about 55.7 million total prevalent cases of chronic low back pain in people aged 18 and over in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The majority of cases were in those aged between 40 and 59.

Features and benefits

• Gain insight into market potential, including a robust 10-year epidemiology forecast of chronic low back pain prevalent cases.

• Understand the key epidemiologic risk factors associated with chronic low back pain.

Table Of Contents

OVERVIEW

Catalyst

Summary

EXECUTIVE SUMMARY

Epidemiology of chronic low back pain

Chronic low back pain in the seven major markets

Datamonitor’s forecast of chronic low back pain

DISEASE DEFINITION AND DIAGNOSTIC CRITERIA

Low back pain background

Low back pain definition and classification

GLOBAL VARIATION AND HISTORICAL TRENDS

Low back pain is difficult to compare due to varying definitions

Low back pain causes significant morbidity but little mortality

Trends in chronic low back pain are unclear

Low back pain in children and adolescents

Prevalence is difficult to quantify due to varying definitions

Risk factors for low back pain in children and adolescents are similar to those in adults

Drivers of Chronic Lower Back Pain Epidemiology

Individual factors

Low back pain prevalence increases with age until peaking by around the age of 60

Gender is not significantly associated with low back pain

Smoking is related to an increased risk of low back pain

High body mass index and limited physical activity are associated with an increased risk of low back pain

Psychosocial factors determine severity of pain and reporting of symptoms

Occupational risk factors

Heavy lifting, twisting, and bending can significantly increase the likelihood of back pain

Sedentary work and consistent whole-body vibration raise the risk of low back pain

Causes associated with low back pain

Lumbar strain or sprain and fractures are the most common causes of back pain

Nerve irritation

Disc degeneration and herniation

Bony encroachment

Bone and joint conditions

Other

Photonic Sensor Market (2011 - 2016) : Global Forecast - By Type (Laser, Biophotonic, Fiber Optic) & Application (Oil & Gas, Military & Aerospace, Energy & Infrastructure, Industrial Automation, Medical and Others)

Published: December 2011
No. of Pages: 159
Price: $ 4650

Photonic Sensor Market - The APAC region is expected to generate $2.61 billion with a CAGR of 21.31%; followed by Europe, North America, and ROW at a CAGR of 14.56%, 13.56%, and 12.94% respectively from 2011 to 2016. Among the APAC countries, China is expected to be the biggest emerging market for photonic sensors.

Photonic sensing technology incorporates emission of light, transmission, deflection, amplification and detection by optical components, instruments, lasers, other light sources, fiber optics, electro-optical instrumentation, and sophisticated nanophotonic systems. It provides smaller, cheaper, lighter and faster components and products, with greater functionality while using less energy.

In recent years, photonics has been recognized as an enabling technology that impacts, extends across, and underpins a whole host of industrial sectors, from healthcare to security, from manufacturing to telecommunications, from energy to the environment, and from aerospace to biotechnology. In all these sectors, photonics sensing activity can be recognized via the intelligent application of light (‘optical radiation’) either in an entirely novel context such as a new photodynamic medical treatment, or as a replacement for an older outdated technology such as signage and lighting based on the use of incandescent lamps. 

Browse All: Electronics Market Research Reports

Photonic sensors are now key technologies in oil and gas exploration in European market, due to which it is the second fastest growing market after APAC region.

A market in industrial category requires global commercialization for it to generate constant revenues for the major players. Currently, photonic sensors face a major challenge in product compatibility and shortage of skilled and trained personnel who lack the required technical expertise to adapt to the latest technology. From an end-user perspective, it is important to recognize that no matter how good the sensor is, there needs to be some level of incorporation into a system, often an instrument, for it to actually fill an economically useful note.

Regarding laser sensors, European market is expected to be slow and reluctant in the next five years; Asia is a strong market whereas U.S. is faced by many highs and lows mainly due to unstable customer preferences and regularly changing technologies